A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19
Data Availability
Plan to Share Individual Participant Data (IPD): Yes Plan Description: All of the individual participant data collected during the trial, after deidentification. Supporting Materials: Study Protocol Supporting Materials: Statistical Analysis Plan (SAP) Supporting Materials: Informed Consent Form (ICF) Supporting Materials: Clinical Study Report (CSR) Supporting Materials: Analytic Code Time Frame: Beginning 3 months and ending 5 years following article publication. Email addresses hramos{at}unicah.edu; hmramos{at}uc.cl Access Criteria: Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For individual participant data meta-analysis.
Subject Area
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2992)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12881)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4677)
- Geriatric Medicine (428)
- Health Economics (737)
- Health Informatics (2974)
- Health Policy (1079)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (434)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4457)
- Nursing (239)
- Nutrition (654)
- Oncology (2319)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1208)
- Primary Care Research (506)
- Public and Global Health (7055)
- Radiology and Imaging (1565)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)